Jeffrey D Capello - Net Worth and Insider Trading

Jeffrey D Capello Net Worth

The estimated net worth of Jeffrey D Capello is at least $10 Million dollars as of 2023-03-31. Jeffrey D Capello is the SVP & CFO of PerkinElmer Inc and owns about 73,139 shares of PerkinElmer Inc (PKI) stock worth over $10 Million. Jeffrey D Capello is also the EVP & CFO of Boston Scientific Corp and owns about 447 shares of Boston Scientific Corp (BSX) stock worth over $22,171. Details can be seen in Jeffrey D Capello's Latest Holdings Summary section.

Transaction Summary of Jeffrey D Capello

To

Jeffrey D Capello Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey D Capello owns 7 companies in total, including Biogen Inc (BIIB) , Millendo Therapeutics Inc (MLND) , and Salarius Pharmaceuticals Inc (SLRX) among others .

Click here to see the complete history of Jeffrey D Capello’s form 4 insider trades.

Insider Ownership Summary of Jeffrey D Capello

Ticker Comapny Transaction Date Type of Owner
BIIB Biogen Inc 2017-12-11 EVP & Chief Financial Officer
MLND Millendo Therapeutics Inc 2018-07-04 director
SLRX Salarius Pharmaceuticals Inc 2015-04-01 director
BSX Boston Scientific Corp 2013-08-29 EVP & Chief Financial Officer
PKI PerkinElmer Inc 2005-01-25 Chief Accounting Officer
TPST Tempest Therapeutics Inc 2013-06-07 director
NEOG Neogen Corp 2022-10-06 director

Jeffrey D Capello Latest Holdings Summary

Jeffrey D Capello currently owns a total of 2 stocks. Among these stocks, Jeffrey D Capello owns 73,139 shares of PerkinElmer Inc (PKI) as of May 31, 2007, with a value of $10 Million and a weighting of 99.77%. Jeffrey D Capello also owns 447 shares of Boston Scientific Corp (BSX) as of November 27, 2013, with a value of $22,171 and a weighting of 0.23%.

Latest Holdings of Jeffrey D Capello

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PKI PerkinElmer Inc 2007-05-31 73,139 131.00 9,581,209
BSX Boston Scientific Corp 2013-11-27 447 49.60 22,171

Holding Weightings of Jeffrey D Capello


Jeffrey D Capello Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 0 transactions in PerkinElmer Inc (PKI) over the past 5 years. The most-recent trade in PerkinElmer Inc is the sale of 37,500 shares on May 31, 2007, which brought Jeffrey D Capello around $990,000.

According to the SEC Form 4 filings, Jeffrey D Capello has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 108,595 shares on November 27, 2013, which brought Jeffrey D Capello around $1 Million.

Insider Trading History of Jeffrey D Capello

Ticker
Company
Date
Buy/Sell
Insider Trading Shares
Shares Change
Price
Cost
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
BSX
Boston Scientific Corp
2013-11-27
Sell
108,595.00
-99.59%
$11.70
$1,270,560.00
447.00
$49.60
323.93%
-
BSX
Boston Scientific Corp
2013-11-26
Sell
85,106.00
-43.84%
$11.82
$1,005,950.00
109,042.00
$49.60
319.63%
-
BSX
Boston Scientific Corp
2013-11-25
Sell
392,504.00
-72.69%
$12.02
$4,717,900.00
147,447.00
$49.60
312.65%
-
BSX
Boston Scientific Corp
2013-08-29
Sell
525,000.00
-78.07%
$10.68
$5,607,000.00
147,447.00
$49.60
364.42%
-
PKI
PerkinElmer Inc
2007-05-31
Sell
37,500.00
-33.89%
$26.40
$990,000.00
73,139.00
$131.00
396.21%
-
PKI
PerkinElmer Inc
2005-10-31
Sell
16,667.00
-30.86%
$22.00
$366,674.00
37,344.00
$131.00
495.45%
-
PKI
PerkinElmer Inc
2004-11-03
Sell
16,667.00
-45.46%
$22.00
$366,674.00
20,000.00
$131.00
495.45%
-
PKI
PerkinElmer Inc
2004-03-03
Sell
12,500.00
-38.46%
$21.60
$270,000.00
20,000.00
$131.00
506.48%
-
Total 8
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey D Capello Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeffrey D Capello Ownership Network

Ownership Network List of Jeffrey D Capello

No Data

Ownership Network Relation of Jeffrey D Capello


Jeffrey D Capello Owned Company Details

What does Biogen Inc do?

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.

Who are the key executives at Biogen Inc?

Jeffrey D Capello is the EVP & Chief Financial Officer of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .

Biogen Inc (BIIB) Insider Trades Summary

Over the past 18 months, Jeffrey D Capello made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .

In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.

Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biogen Inc Insider Transactions

20/Page
Total 0
Ticker
Insider
Position
Date
Buy/Sell
Shares
Shares Owned
Trade Price($)
Trade Percentage(%)
Cost($1000)
Price change since trade(%)
Share ownership details
Filing Date
20/Page
Total 0

Jeffrey D Capello Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey D Capello. You might contact Jeffrey D Capello via mailing address: C/o Neogen Corp., 620 Lesher Place, Lansing Mi 48912.